Clinical trials
Phase 1/2 trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
99 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 7 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 11 |
| 2020 | 7 |
| 2021 | 8 |
| 2022 | 6 |
| 2023 | 12 |
| 2024 | 12 |
| 2025 | 16 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 31 |
| Completed | 27 |
| Active, not recruiting | 19 |
| Terminated | 10 |
| Unknown status | 9 |
| Suspended | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 15 |
| Janssen Research & Development, LLC | 6 |
| Novartis Pharmaceuticals | 5 |
| Acibadem University | 4 |
| AstraZeneca | 4 |
| BioNTech SE | 4 |
| GlaxoSmithKline | 4 |
| TC Erciyes University | 3 |
| Bayer | 2 |
| BeOne Medicines | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 13 |
| Breast Neoplasms | 6 |
| Neoplasms | 6 |
| Carcinoma, Transitional Cell | 5 |
| Lymphoma, Non-Hodgkin | 5 |
| Esophageal Squamous Cell Carcinoma | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Melanoma | 4 |
| Recurrence | 4 |
| Urinary Bladder Neoplasms | 4 |
Trials
Showing 26 to 50 of 99. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.